Tang Capital Management Llc (Kevin Tang) - Significant Ownership

Notable people
Kevin Tang
Signature - Title
/s/ Kevin Tang - Manager
Location
San Diego, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Tang Capital Management Llc.

Significant Ownership of Tang Capital Management Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ITOS ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $102K -$39M 10K -99.7% TANG CAPITAL MANAGEMENT, LLC Aug 29, 2025
CRGX Cargo Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $44.7K -$13.6M 10K -99.7% TANG CAPITAL MANAGEMENT, LLC Aug 19, 2025
ALLK Allakos Inc. Common Stock, par value $0.001 per share 100% $3.2K -$2.78M 10K -99.9% TANG CAPITAL MANAGEMENT, LLC May 15, 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $60.1M $12.9M 17.2M +27.3% TANG CAPITAL MANAGEMENT, LLC Sep 30, 2025
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.9% $52.1M 4.94M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share 9.9% $10.9M 7.01M TANG CAPITAL MANAGEMENT, LLC Jan 17, 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 9.9% $6.21M 8.22M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 9.9% $1.53M 3.81M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.6% $7.38M 5.86M TANG CAPITAL MANAGEMENT, LLC Mar 3, 2025
CYBN Cybin Inc. Common Stock, no par value 9.1% $10.5M $2.87M 1.83M +37.6% TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
PMVP PMV Pharmaceuticals, Inc. Common Stock, par value $0.00001 per share 8.9% $6.7M 4.72M TANG CAPITAL MANAGEMENT, LLC Sep 16, 2025
GLPG Galapagos NV Ordinary shares, no par value 8.4% $193M $22.5M 5.56M +13.2% TANG CAPITAL MANAGEMENT, LLC Oct 27, 2025
DERM Journey Medical Corporation Common Stock, par value $0.0001 per share 8% $10.9M 1.85M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
EOLS Evolus, Inc. Common Stock, par value $0.00001 per share 7.9% $47.7M 5M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
KROS Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.9% $38.3M 2.42M TANG CAPITAL MANAGEMENT, LLC Oct 15, 2025
AUPH Aurinia Pharmaceuticals Inc. Common Shares, no par value 7.3% $74.3M 10M TANG CAPITAL MANAGEMENT, LLC Feb 28, 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 7% $22.1M $8.7M 11.1M +64.7% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
DTIL Precision BioSciences, Inc. Common Stock, par value $0.000005 per share 6.4% $2.96M 673K TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.9% $114M 2.45M TANG CAPITAL MANAGEMENT, LLC Mar 31, 2025
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.3% $39.1M 3.2M TANG CAPITAL MANAGEMENT, LLC Apr 24, 2025
IMCR Immunocore Holdings plc American Depositary Shares, each representing one ordinary share, nominal value GBP 0.002 per share 5.2% $94.7M 2.61M TANG CAPITAL MANAGEMENT, LLC Oct 17, 2025
KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share 5.2% $44.4M 2.18M TANG CAPITAL MANAGEMENT, LLC Mar 28, 2025
CBIO Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 5.04% $8.79M 700K TANG CAPITAL MANAGEMENT, LLC Oct 2, 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 5% $1.18M -$1.11M 3.12M -48.5% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 4.8% $1.73M -$260K 3.4M -13.1% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 3.5% $368K -$550K 66.9K -59.9% TANG CAPITAL MANAGEMENT, LLC Sep 30, 2025
OTLK Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share 3.4% $1.64M -$436K 1.5M -21.1% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
HLVX HilleVax, Inc. Common Stock, par value $0.0001 per share 0% $0 -$10.1M 0 -100% TANG CAPITAL MANAGEMENT, LLC Sep 17, 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share 0% $0 -$821K 0 -100% TANG CAPITAL MANAGEMENT, LLC Sep 30, 2025
MNPR Monopar Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 TANG CAPITAL MANAGEMENT, LLC Dec 31, 2024
SLRN Acelyrin, Inc. Common Stock, par value $0.00001 per share 0% $0 -$21.6M 0 -100% TANG CAPITAL MANAGEMENT, LLC May 21, 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 0% $0 -$5.78M 0 -100% TANG CAPITAL MANAGEMENT, LLC Sep 30, 2025

Schedules 13D/G Reported by Tang Capital Management Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.